Nippon Shinyaku Co. Ltd. | Ownership
Companies that own Nippon Shinyaku Co. Ltd.
Asset Management One Co., Ltd.
3,356,400
4.78%
-613,000
0.14%
08/15/2018
FIL Investments (Japan) Ltd.
3,048,700
4.34%
-1,328,200
1.45%
01/31/2018
Nomura Asset Management Co., Ltd.
1,970,399
2.81%
27,199
0.07%
07/31/2018
Wellington Management Co. LLP
1,615,540
2.29%
-4,500
0.02%
08/31/2018
OppenheimerFunds, Inc.
1,436,700
2.04%
0
0.05%
02/28/2018
The Vanguard Group, Inc.
1,198,423
1.71%
6,700
0%
07/31/2018
Schroder Investment Management Ltd.
688,470
0.98%
-29,100
0.03%
06/30/2018
OrbiMed Advisors LLC
559,287
0.8%
-232,923
0.34%
09/30/2017
Norges Bank Investment Management
540,900
0.77%
-22,432
0%
12/31/2017
BlackRock Fund Advisors
431,700
0.62%
-200
0%
09/06/2018
| Address |
14 Nishinosho-Monguchi-cho
Kyoto Kyoto 601
Japan
|
|
Employees
|
- |
| Website |
http://www.nippon-shinyaku.co.jp |
| Updated |
07/08/2019 |
| Nippon Shinyaku Co., Ltd. engages in the manufacture and sale of pharmaceuticals and foodstuffs. Its operations are carried out through the following segments: Pharmaceuticals and Functional Food. The Pharmaceuticals segment develops and distributes drugs that treat urological diseases, inflammation, allergies, hematological malignancies, cardiovascular and metabolic diseases, and gastrointestinal disorders. |
